ABSCIENCES (EPA:AB) AB Science announces that a new independent publication confirms the role of masitinib as a potential therapy in pancreatic cancer
Transparency directive : regulatory news
23/02/2021 08:02
ABSCIENCES's latest news
13/03/2024 12:58
07/03/2024 15:20
06/03/2024 20:21
29/02/2024 11:49
26/02/2024 18:32
28/11/2023 19:22
27/11/2023 08:04
29/09/2023 19:49
18/09/2023 18:05
01/06/2023 18:01
Other stories
20/04/2024 10:39
20/04/2024 13:54
20/04/2024 14:31
20/04/2024 14:36
20/04/2024 08:26
20/04/2024 11:20
20/04/2024 11:56
20/04/2024 13:27
20/04/2024 13:34
19/04/2024 22:08
20/04/2024 11:25
20/04/2024 12:21
Man's leg 'snapped in half' 30 minutes into flight after plane hit by severe turbulence - The Mirror
20/04/2024 13:26
20/04/2024 14:01
18/04/2024 17:06
20/04/2024 05:34
19/04/2024 01:56
20/04/2024 05:35
19/04/2024 12:17
19/04/2024 18:00
20/04/2024 10:14
20/04/2024 15:47
20/04/2024 07:00
19/04/2024 15:48
20/04/2024 03:58
20/04/2024 08:21
20/04/2024 12:30
20/04/2024 12:08
20/04/2024 14:19
20/04/2024 10:29
20/04/2024 09:37
19/04/2024 21:18
19/04/2024 14:00
19/04/2024 23:53
20/04/2024 10:53
20/04/2024 08:56
20/04/2024 10:53